Cargando…
Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome
BACKGROUND: Gitelman syndrome (GS), an inherited autosomal recessive salt-losing renal tubulopathy caused by mutations in SLC12A3 gene, has been associated with normal prostaglandin E2 (PGE2) levels since 1995 by a study involving 11 clinically diagnosed patients. However, it is difficult to explain...
Autores principales: | Peng, Xiaoyan, Jiang, Lanping, Chen, Chen, Qin, Yan, Yuan, Tao, Wang, Ou, Xing, Xiaoping, Li, Xuemei, Nie, Min, Chen, Limeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263/ https://www.ncbi.nlm.nih.gov/pubmed/28700713 http://dx.doi.org/10.1371/journal.pone.0180811 |
Ejemplares similares
-
Glucose tolerance and insulin responsiveness in Gitelman syndrome patients
por: Yuan, Tao, et al.
Publicado: (2017) -
Hydrochlorothiazide Test as a Tool in the Diagnosis of Gitelman Syndrome in Chinese Patients
por: Peng, Xiaoyan, et al.
Publicado: (2018) -
Frequent SLC12A3 mutations in Chinese Gitelman syndrome patients: structure and function disorder
por: Jiang, Lanping, et al.
Publicado: (2021) -
Clinicopathological Features of Gitelman Syndrome with Proteinuria and Renal Dysfunction
por: Zhang, Lei, et al.
Publicado: (2023) -
Association of urinary prostaglandin E2 metabolite and mortality among adults
por: Wen, Wanqing, et al.
Publicado: (2022)